久久综合九色综合欧洲色-久久综合九色综合桃花-久久综合九色综合网站-久久综合久久综合九色-亚洲影院在线播放-亚洲永久视频

技術文章您現在的位置:首頁 > 技術文章 > Broadpharm提供可切割和不可切割Linker

Broadpharm提供可切割和不可切割Linker

更新時間:2023-08-28   點擊次數:922次

Antibody-Drug Conjugates (ADCs) are composed of a drug (payload) and antibody (mAbs) that are bound using linkages that are specifically designed to deliver the payload to the intended target environment. ADCs are designed to sparing healthy cells by targeting specific cancer types.

This article expands upon the linker information in the ADC Linker Technology in 2021 article. Specifically, the cleavable and non-cleavable categories of ADC linkers. Cleavable linkers use inherent properties of tumor cells for selective release of payloads from the ADCs. There are three commonly used mechanisms for cleavable linkers; protease-sensitive peptide linkers, acid sensitive hydrazone linkers, and glutathione-sensitive disulfide linkers.

Protease-sensitive cleavable linkers use the dominant proteases found in tumor cell lysosomes for recognition and cleavage of a specific peptide sequence in the linker. A commonly used ADC linker makes use of a valine-citrulline (vc) dipeptide, first discovered by Dubowchik et al., as an intracellular cleavage mechanism by cathepsin B.

diagram of adcetris
Figure 1. Adcetris with enzymatically cleavable val-cit linkage.

Acid-sensitive linkers use a lower pH in the endosomal (pH = 5-6) and lysosomal (pH = 4.8) compartments, in contrast to cytosol (pH = 7.4) to trigger hydrolysis of acid labile groups within a linker such as hydrazone.

Glutathione-sensitive linkers use higher concentrations of intracellular glutathione that in the plasma. This causes disulfide bridges to release the payload upon reduction by glutathione.

Cleavable linkers may also help with destroying cancer cell adjacent to their targets through a process referred to as "bystander effect". The bystander effect occurs when the payload is released near the targeted cancer cell, or a payload diffuses out of one cancer cell and then is absorbed by a second cancer cell.

Non-cleavable linkers only degrade when the anti-body degrades. Release of the payload occurs mainly in the lysosome after internalization of the ADC and degradation of both the antibody and linker. This may be an advantage since it could lead to a lower risk of systemic toxicity. Figure 2 shows an example of Kadcyla, which uses SMCC crosslinker as the non-cleavable linker.

diagram of kadcyla
Figure 2. Kadcyla, shown with the linker in green and the payload in orange, was designed with a non-cleavable linkage.

BroadPharm offers a wide array of different ADC Linkers, PEG Linkers to empower our customer's advanced research worldwide. These compounds feature great aqueous solubility, smart choice of PEG length, and a broad selection of functional groups to choose from.

Journal Reference:

1.Editorial Team, "FDA Grants Accelerated Approval for Sacituzumab Govitecan in Metastatic Triple-negative Breast Cancer", ADC Review (2020)

2.FDA Press Release, "FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma", (2021)

3.Staudacher, Brown, "Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?", Br J Cancer 117, (2017): 1736-1742

    訂購咨詢

    靶點科技(北京)有限公司


靶點科技(北京)有限公司

靶點科技(北京)有限公司

地址:中關村生命科學園北清創意園2-4樓2層

© 2025 版權所有:靶點科技(北京)有限公司  備案號:京ICP備18027329號-2  總訪問量:302187  站點地圖  技術支持:化工儀器網  管理登陸

主站蜘蛛池模板: 色视频在线观看完整免费版 | 男女羞羞视频网站 | 五月婷婷婷 | 激情欧美成人狠狠色金八天国 | 日韩久久免费视频 | 国产精品青青青高清在线 | 久久国产亚洲偷自 | 男女爱视频免费高清在线观看 | 成人免费观看视频 | 久久综合免费视频 | 91麻豆精品在线观看 | 香蕉视频在线精品 | 免费在线观看污网站 | 天堂在线视频网站 | 四川幻女一级毛片 | 日韩免费高清视频 | 男人和女人真曰批全过程 | 日韩在线观看视频免费 | 欧美中文在线视频 | 日日操夜夜摸 | 四虎影音在线 | 爱逼综合 | 青青草a免费线观a | 麻豆xxxxhd videos 麻豆xx | 天堂网最新版www | 黄网站在线免费 | 久久笫一福利免费导航 | 韩国理论毛片a级 | 日本久久中文字幕 | 欧美激情亚洲精品日韩1区2区 | 日韩福利在线 | 麻豆成人精品国产免费 | 免费在线视频日本 | 男人色综合| 国产日韩欧美中文字幕 | 日韩大片| 久久亚洲国产高清 | 欧美日韩一 | 99视频免费高清完整版 | 免费精品美女久久久久久久久 | 欧美日韩精品在线观看 |